Day: October 8, 2017

The expert panel also discusses new compounds in development for various hematologic malignancies.

The expert panel also discusses new compounds in development for various hematologic malignancies, and the hurdles they need in order in order be be viable options in this market. – Mentioned companies and partnerships in this report includes: Allos, Arno Therapeutics, Antisoma, Biogen Idec / Elan, Biotest / ImmunoGen, Bristol-Myers Squibb Bristol-Myers Squibb / Facet,… Read more The expert panel also discusses new compounds in development for various hematologic malignancies.